ALLO - short squeeze candidate This is not a financial advice!
SL under 4.4
1 TP 6.3
2 TP 8.0
3 TP 10
Only 82.54M float
49.68 short float
Most info on the chart.
Trade carefully!
0%
0%
0%
0%
0%
−2.45USD
−332.632MUSD
243KUSD
106.1M
About Allogene Therapeutics, Inc.
Sector
Industry
CEO
David D. Chang
Website
Headquarters
South San Francisco
Employees
361
Founded
2017
ISIN
US0197701065
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.
Buy Opportunity in ALLOThis company is oversold in 1 Hr and $ Hrs charts. It show as bottom fishing opportunity in my Rader.
Please check other signals I released so far.
ALLOALLO Long🚀📊
PLEASE WAIT FOR ENTERING POINT
It is not financial advice. This is my opinion. Please check yourselves and invest in the symbols that you think have a huge potential to reach the best results.
please leave us your opinion and reviews.🙏
Good Luck 👍
ALLOLONG-TERM: Bullish gartley with the PCZ at an iceline, classic bullish divergence on daily/weekly. (not financial advice)
ALLO Long part 2There was a slight change in the markup. The goals remained the same. Medium-term 41-46$
BUY to ALLOGENE THERAPEUTICS DailyHello traders, ALLOGENE THERAPEUTICS is in a bullish movement with a candle carrying water and a slowdown in the purchase volume issued. On TIMEFRAME M1 we observed a form of marubozu followed by a short shadow with a return of negotiated buy volume, it tried to fill a bearish breakout gap. To move
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ALLO is featured.
